Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Clinical trial NCT05927428 · RECRUITING
Trial details
- NCT number
- NCT05927428
- Sponsor
- BRIM Biotechnology Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2025-08-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.